{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:28:24Z","timestamp":1786512504239,"version":"build-2736575974"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Glob. Women\u2019s Health"],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To compare health-related quality of life (HRQoL) in women with normogonadotropic ovulatory dysfunction, specifically polycystic ovary syndrome (PCOS) and hypothalamic-pituitary-ovarian axis dysfunction (HPOD), to that of regularly menstruating women, and to evaluate the impact of selected clinical and biochemical parameters on HRQoL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>HRQoL across nine domains was compared using the RAND 36-Item Health Survey among women with regular and irregular menstruation. Correlations between clinical parameters and HRQoL scores were examined, along with correlations between biochemical parameters and HRQoL scores in anovulatory women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HRQoL in the domains of Role Limitations Due to Physical Health (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024), Role Limitations Due to Emotional Problems (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), Energy\/Fatigue (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006), Emotional Wellbeing (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01), Social Functioning (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007), General Health (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), and Health Change (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005) was significantly better in regularly menstruating women. No significant differences were observed in HRQoL between women with PCOS and those with HPOD (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;gt;\u20090.05). Women with PCOS phenotype D had a better Physical Functioning score compared to those with PCOS A and B (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017). Significant negative correlations were observed between Ferriman-Gallwey and Ludwig scale scores and HRQoL aspects in the entire cohort, and between dysmenorrhea, heavy menstrual bleeding, BMI, CRP concentrations, dyslipidemia, and insulin resistance and HRQoL in anovulatory women. Testosterone concentrations did not correlate with HRQoL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HRQoL in women with ovulatory dysfunction was worse than that of women with regular ovulation in most HRQoL domains, with no differences between PCOS and HPOD. Significant correlations were identified between clinical and biochemical health indicators and the assessed HRQoL domains.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgwh.2026.1806970","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:44:57Z","timestamp":1786509897000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Health-related quality of life in women with normogonadotropic ovulatory dysfunction: a prospective cohort study"],"prefix":"10.3389","volume":"7","author":[{"given":"Iwona","family":"Gawron","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Chair of Gynecology and Obstetrics, Jagiellonian University Medical College","place":["Krakow, Poland"]},{"name":"Clinical Department of Gynecological Endocrinology and Gynecological Oncology, University Hospital in Krakow","place":["Krakow, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Brodowicz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Chair of Clinical Biochemistry, Jagiellonian University Medical College","place":["Krakow, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"Baran","sequence":"additional","affiliation":[{"name":"Clinical Department of Gynecological Endocrinology and Gynecological Oncology, University Hospital in Krakow","place":["Krakow, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Bromboszcz","sequence":"additional","affiliation":[{"name":"Clinical Department of Gynecological Endocrinology and Gynecological Oncology, University Hospital in Krakow","place":["Krakow, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Wielgus","sequence":"additional","affiliation":[{"name":"Clinical Department of Gynecological Endocrinology and Gynecological Oncology, University Hospital in Krakow","place":["Krakow, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jach","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Chair of Gynecology and Obstetrics, Jagiellonian University Medical College","place":["Krakow, Poland"]},{"name":"Clinical Department of Gynecological Endocrinology and Gynecological Oncology, University Hospital in Krakow","place":["Krakow, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"key":"B2","first-page":"1","article-title":"Report of a WHO scientific group","volume":"514","year":"1976","journal-title":"World Health Organ Tech Rep Ser"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/biomedicines7010005","article-title":"Hypothalamic-pituitary-ovarian axis disorders impacting female fertility","volume":"7","author":"Mikhael","year":"2019","journal-title":"Biomedicines"},{"key":"B4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/s1472-6483(10)61728-2","article-title":"IVF Outcome in anovulatory infertility (WHO group 2)\u2013including polycystic ovary syndrome\u2013following previous unsuccessful ovulation induction","volume":"7","author":"Mulders","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"B5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/humupd\/dmaf030","article-title":"Prevalence of polycystic ovary syndrome: a global and regional systematic review and meta-analysis","volume":"32","author":"Neven","year":"2026","journal-title":"Hum Reprod Update"},{"key":"B6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/humupd\/dms019","article-title":"Health and fertility in World Health Organization group 2 anovulatory women","volume":"18","author":"Baird","year":"2012","journal-title":"Hum Reprod Update"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.fertnstert.2021.08.038","article-title":"Fertility evaluation of infertile women: a committee opinion","volume":"116","author":"Penzias","year":"2021","journal-title":"Fertil Steril"},{"key":"B8","doi-asserted-by":"publisher","first-page":"591837","DOI":"10.3389\/fendo.2020.591837","article-title":"Practical clinical and diagnostic pathway for the investigation of the infertile couple","volume":"11","author":"Garolla","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e49146","DOI":"10.7759\/cureus.49146","article-title":"The impact of irregular menstruation on health: a review of the literature","volume":"15","author":"Attia","year":"2023","journal-title":"Cureus"},{"key":"B10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/humupd\/dmad034","article-title":"Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"30","author":"Pastoor","year":"2024","journal-title":"Hum Reprod Update"},{"key":"B11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12020-018-1692-3","article-title":"Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"62","author":"Brutocao","year":"2018","journal-title":"Endocrine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e2533823","DOI":"10.1001\/jamanetworkopen.2025.33823","article-title":"Premenstrual disorders and quality of life in Sweden","volume":"8","author":"Wang","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s11136-021-02826-0","article-title":"How is quality of life defined and assessed in published research?","volume":"30","author":"Costa","year":"2021","journal-title":"Qual Life Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"CD007506","DOI":"10.1002\/14651858.CD007506.pub4","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"CD008189","DOI":"10.1002\/14651858.CD008189.pub3","article-title":"Preconception lifestyle advice for people with infertility","volume":"4","author":"Boedt","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1297841","DOI":"10.3389\/fendo.2024.1297841","article-title":"The effects of behavioral intervention on anthropometric, clinical, and biochemical parameters in patients with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"15","author":"Xie","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/clinem\/dgab613","article-title":"Healthcare-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences","volume":"107","author":"Riestenberg","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1642369","DOI":"10.3389\/frph.2025.1642369","article-title":"Global trends and health system impact on polycystic ovary syndrome: a comprehensive analysis of age-stratified females from 1990 to 2021","volume":"7","author":"Zeng","year":"2025","journal-title":"Front Reprod Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/hec.4730020305","article-title":"The RAND 36-item health survey 1.0","volume":"2","author":"Hays","year":"1993","journal-title":"Health Econ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br J Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/IJWH.S165794","article-title":"Measures of health-related quality of life in PCOS women: a systematic review","volume":"10","author":"Behboodi Moghadam","year":"2018","journal-title":"Int J Womens Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"hoae065","DOI":"10.1093\/hropen\/hoae065","article-title":"Evidence-based guideline: premature ovarian insufficiency","volume":"2024","author":"Panay","year":"2024","journal-title":"Hum Reprod Open"},{"key":"B25","doi-asserted-by":"publisher","first-page":"103102","DOI":"10.1016\/j.arcmed.2024.103102","article-title":"Overview of hyperprolactinemia: general approach and reproductive health implications","volume":"55","author":"Haidenberg-David","year":"2024","journal-title":"Arch Med Res"},{"key":"B26","volume-title":"R: A Language and Environment for Statistical Computing","year":"2024"},{"key":"B27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/aogs.12792","article-title":"Women with minor menstrual irregularities have increased risk of preeclampsia and low birthweight in spontaneous pregnancies","volume":"95","author":"Bonnesen","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12905-022-01654-9","article-title":"Prevalence of dysmenorrhea among reproductive age group in Saudi women","volume":"22","author":"Bakhsh","year":"2022","journal-title":"BMC Womens Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5468\/ogs.2019.62.5.329","article-title":"Polycystic ovarian morphology is associated with primary dysmenorrhea in young Korean women","volume":"62","author":"Jeong","year":"2019","journal-title":"Obstet Gynecol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"100131","DOI":"10.1016\/j.jeud.2025.100131","article-title":"Understanding dysmenorrhea in individuals with polycystic ovary morphology (PCOM)","volume":"12","author":"Romeo","year":"2025","journal-title":"J Endometriosis Uterine Disord"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0310445","DOI":"10.1371\/journal.pone.0310445","article-title":"Women's environmental quality of life is key to their overall quality of life and health: global evidence from the WHOHRQOL-100","volume":"19","author":"Skevington","year":"2024","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11136-013-0473-y","article-title":"Quality of life in female cancer survivors: is it related to ovarian reserve?","volume":"23","author":"Kondapalli","year":"2014","journal-title":"Qual Life Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11102-024-01392-1","article-title":"Quality of life in prolactinoma: a systematic review","volume":"27","author":"Castle-Kirszbaum","year":"2024","journal-title":"Pituitary"},{"key":"B34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1530\/EC-17-0171","article-title":"Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study","volume":"6","author":"Soto-Pedre","year":"2017","journal-title":"Endocr Connect"},{"key":"B35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ejogrb.2022.02.014","article-title":"Comparison of health-related quality of life in different polycystic ovary syndrome phenotypes: a cross-sectional study","volume":"271","author":"Li","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13048-021-00811-2","article-title":"Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study","volume":"14","author":"Fatemeh","year":"2021","journal-title":"J Ovarian Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12905-022-01983-9","article-title":"Sexuality and psychological well-being in different polycystic ovary syndrome phenotypes compared with healthy controls: a cross-sectional study","volume":"22","author":"Bahadori","year":"2022","journal-title":"BMC Womens Health"},{"key":"B38","doi-asserted-by":"publisher","first-page":"100159","DOI":"10.1016\/j.endmts.2024.100159","article-title":"When one size does not fit all: reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments","volume":"14","author":"Unfer","year":"2024","journal-title":"Endocr Metab Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-024-02329-y","article-title":"Psychological symptoms and brain activity alterations in women with PCOS and their relation to the reduced quality of life: a narrative review","volume":"47","author":"Pinto","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"103325","DOI":"10.1016\/j.arcmed.2025.103325","article-title":"Hyperandrogenemia and systemic low-grade inflammation in normogonadotropic anovulation: a prospective cohort study","volume":"57","author":"Gawron","year":"2025","journal-title":"Arch Med Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e029861","DOI":"10.1136\/bmjopen-2019-029861","article-title":"C reactive protein level as a marker for dyslipidemia, diabetes and metabolic syndrome: results from the Korea national health and nutrition examination survey","volume":"9","author":"Jeong","year":"2019","journal-title":"BMJ Open"},{"key":"B42","doi-asserted-by":"publisher","first-page":"690","DOI":"10.2337\/diacare.28.3.690","article-title":"Cardiovascular disease in U.S. Patients with metabolic syndrome, diabetes, and elevated C-reactive protein","volume":"28","author":"Malik","year":"2005","journal-title":"Diabetes Care"},{"key":"B43","doi-asserted-by":"publisher","first-page":"103065","DOI":"10.1016\/j.arcmed.2024.103065","article-title":"Atherogenic combined Index: validation of a coronary artery disease predictive biomarker","volume":"55","author":"Toprak","year":"2024","journal-title":"Arch Med Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1176\/appi.ajp.2020.20060947","article-title":"Elevated c-reactive protein in patients with depression, independent of genetic, health, and psychosocial factors: results from the UK biobank","volume":"178","author":"Pitharouli","year":"2021","journal-title":"Am J Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jpain.2023.09.008","article-title":"C-Reactive protein (CRP) is associated with chronic pain independently of biopsychosocial factors","volume":"25","author":"Farrell","year":"2024","journal-title":"J Pain"},{"key":"B46","doi-asserted-by":"publisher","first-page":"583","DOI":"10.5935\/1518-0557.20250040","article-title":"Reproductive prognosis factors in women with infertility and polycystic ovary syndrome undergoing in vitro fertilization techniques","volume":"29","author":"Ribeiro","year":"2025","journal-title":"JBRA Assist Reprod"},{"key":"B47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.5935\/1518-0557.20240049","article-title":"Anti-M\u00fcllerian hormone as a predictor of the number of oocytes obtained during in vitro fertilization treatments","volume":"28","author":"Reis","year":"2024","journal-title":"JBRA Assist Reprod"},{"key":"B48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5935\/1518-0557.20240095","article-title":"Predictors of pregnancy after artificial insemination in women with polycystic ovary syndrome","volume":"29","author":"Moreira","year":"2025","journal-title":"JBRA Assist Reprod"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1064937","DOI":"10.3389\/fendo.2022.1064937","article-title":"A systematic review of lived experiences of people with polycystic ovary syndrome highlights the need for holistic care and co-creation of educational resources","volume":"13","author":"Lau","year":"2022","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Frontiers in Global Women's Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2026.1806970\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:45:02Z","timestamp":1786509902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2026.1806970\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":49,"alternative-id":["10.3389\/fgwh.2026.1806970"],"URL":"https:\/\/doi.org\/10.3389\/fgwh.2026.1806970","relation":{},"ISSN":["2673-5059"],"issn-type":[{"value":"2673-5059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1806970"}}